These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 15293560

  • 21. Factors associated with the release of cardiac troponin T following percutaneous transluminal coronary angioplasty.
    Abbas SA, Glazier JJ, Wu AH, Dupont C, Green SF, Pearsall LA, Waters DD, McKay RG.
    Clin Cardiol; 1996 Oct; 19(10):782-6. PubMed ID: 8896910
    [Abstract] [Full Text] [Related]

  • 22. New universal definition of myocardial infarction applicable after complex percutaneous coronary interventions?
    Locca D, Bucciarelli-Ducci C, Ferrante G, La Manna A, Keenan NG, Grasso A, Barlis P, Del Furia F, Prasad SK, Kaski JC, Pennell DJ, Di Mario C.
    JACC Cardiovasc Interv; 2010 Sep; 3(9):950-8. PubMed ID: 20850095
    [Abstract] [Full Text] [Related]

  • 23. Lipid peroxidation as determined by plasma isoprostanes is related to disease severity in mild asthma.
    Wood LG, Fitzgerald DA, Gibson PG, Cooper DM, Garg ML.
    Lipids; 2000 Sep; 35(9):967-74. PubMed ID: 11026617
    [Abstract] [Full Text] [Related]

  • 24. Elevated levels of 8-iso-prostaglandin F2alpha in acute coronary syndromes are associated with systemic and local platelet activation.
    Szułdrzyński K, Zalewski J, Machnik A, Zmudka K.
    Pol Arch Med Wewn; 2010 Sep; 120(1-2):19-24. PubMed ID: 20150840
    [Abstract] [Full Text] [Related]

  • 25. Staccato reperfusion prevents reperfusion injury in patients undergoing coronary angioplasty: a 1-year follow-up pilot study.
    Iliodromitis EK, Paraskevaidis IA, Fountoulaki K, Farmakis D, Andreadou I, Antoniadis A, Ikonomidis I, Leftheriotis D, Kremastinos DT.
    Atherosclerosis; 2009 Jun; 204(2):497-502. PubMed ID: 19038389
    [Abstract] [Full Text] [Related]

  • 26. Oxidative stress and inflammation due to peripheral polymorphonuclear leukocytes after coronary angiography vs percutaneous coronary intervention.
    Farah R, Shurtz-Swirski R, Bolotin Y, Brezins M.
    Minerva Cardioangiol; 2008 Apr; 56(2):189-95. PubMed ID: 18319697
    [Abstract] [Full Text] [Related]

  • 27. Detection and quantification of embolic particles during percutaneous coronary intervention to stable plaque: it correlates to coronary flow dynamics and myocardial damage.
    Okamura A, Ito H, Iwakura K, Kawano S, Kurotobi T, Date M, Inoue K, Ogihara T, Fujii K.
    Catheter Cardiovasc Interv; 2007 Feb 15; 69(3):425-31. PubMed ID: 17191241
    [Abstract] [Full Text] [Related]

  • 28. Remote ischemic preconditioning immediately before percutaneous coronary intervention does not impact myocardial necrosis, inflammatory response, and circulating endothelial progenitor cell counts: a single center randomized sham controlled trial.
    Prasad A, Gössl M, Hoyt J, Lennon RJ, Polk L, Simari R, Holmes DR, Rihal CS, Lerman A.
    Catheter Cardiovasc Interv; 2013 May 15; 81(6):930-6. PubMed ID: 22517646
    [Abstract] [Full Text] [Related]

  • 29. Effect on door-to-balloon time of immediate transradial percutaneous coronary intervention on culprit lesion in ST-elevation myocardial infarction compared to diagnostic angiography followed by primary percutaneous coronary intervention.
    Plourde G, Abdelaal E, Bataille Y, MacHaalany J, Déry JP, Déry U, Larose É, De Larochellière R, Gleeton O, Barbeau G, Roy L, Costerousse O, Bertrand OF.
    Am J Cardiol; 2013 Mar 15; 111(6):836-40. PubMed ID: 23313341
    [Abstract] [Full Text] [Related]

  • 30. C-reactive protein and myocardial infarction during percutaneous coronary intervention.
    Saleh N, Svane B, Velander M, Nilsson T, Hansson LO, Tornvall P.
    J Intern Med; 2004 Jan 15; 255(1):33-9. PubMed ID: 14687236
    [Abstract] [Full Text] [Related]

  • 31. Glycoprotein IIB/IIIA inhibitor to reduce postpercutaneous coronary intervention myonecrosis and improve coronary flow in diabetics: the 'OPTIMIZE-IT' pilot randomized study.
    Talarico GP, Brancati M, Burzotta F, Porto I, Trani C, De Vita M, Todaro D, Giammarinaro M, Leone AM, Niccoli G, Andreotti F, Mazzari MA, Schiavoni G, Crea F.
    J Cardiovasc Med (Hagerstown); 2009 Mar 15; 10(3):245-51. PubMed ID: 19262211
    [Abstract] [Full Text] [Related]

  • 32. Colocalization of thin-cap fibroatheroma and spotty calcification is a powerful predictor of procedure-related myocardial injury after elective coronary stent implantation.
    Ueda T, Uemura S, Watanabe M, Sugawara Y, Soeda T, Okayama S, Takeda Y, Kawata H, Kawakami R, Saito Y.
    Coron Artery Dis; 2014 Aug 15; 25(5):384-91. PubMed ID: 24681754
    [Abstract] [Full Text] [Related]

  • 33. Lack of efficacy of clopidogrel pre-treatment in the prevention of myocardial damage after elective stent implantation.
    van der Heijden DJ, Westendorp IC, Riezebos RK, Kiemeneij F, Slagboom T, van der Wieken LR, Laarman GJ.
    J Am Coll Cardiol; 2004 Jul 07; 44(1):20-4. PubMed ID: 15234399
    [Abstract] [Full Text] [Related]

  • 34. Impact of multi-vessel therapy to the risk of periprocedural myocardial injury after elective coronary intervention: exploratory study.
    Chen ZW, Yang HB, Chen YH, Ma JY, Qian JY, Ge JB.
    BMC Cardiovasc Disord; 2017 Feb 27; 17(1):69. PubMed ID: 28241795
    [Abstract] [Full Text] [Related]

  • 35. Cardiac troponin T and I and creatine kinase-MB as markers of myocardial injury and predictors of outcome following percutaneous coronary intervention.
    Nageh T, Sherwood RA, Harris BM, Byrne JA, Thomas MR.
    Int J Cardiol; 2003 Dec 27; 92(2-3):285-93. PubMed ID: 14659867
    [Abstract] [Full Text] [Related]

  • 36. High high-density lipoprotein-cholesterol reduces risk and extent of percutaneous coronary intervention-related myocardial infarction and improves long-term outcome in patients undergoing elective percutaneous coronary intervention.
    Sattler KJ, Herrmann J, Yün S, Lehmann N, Wang Z, Heusch G, Sack S, Erbel R, Levkau B.
    Eur Heart J; 2009 Aug 27; 30(15):1894-902. PubMed ID: 19474052
    [Abstract] [Full Text] [Related]

  • 37. Cardiac troponin T, creatine kinase, and its isoform release after successful percutaneous transluminal coronary angioplasty with or without stenting.
    Shyu KG, Kuan PL, Cheng JJ, Hung CR.
    Am Heart J; 1998 May 27; 135(5 Pt 1):862-7. PubMed ID: 9588418
    [Abstract] [Full Text] [Related]

  • 38. Routine early coronary angioplasty versus ischaemia-guided angioplasty after thrombolysis in acute ST-elevation myocardial infarction: a meta-analysis.
    D'Souza SP, Mamas MA, Fraser DG, Fath-Ordoubadi F.
    Eur Heart J; 2011 Apr 27; 32(8):972-82. PubMed ID: 21036776
    [Abstract] [Full Text] [Related]

  • 39. Relation of minor cardiac troponin I elevation to late cardiac events after uncomplicated elective successful percutaneous transluminal coronary angioplasty for angina pectoris.
    Bertinchant JP, Polge A, Ledermann B, Genet L, Fabbro-Peray P, Raczka F, Brunet J, Poirey S, Wittenberg O, Pernel I, Nigond J.
    Am J Cardiol; 1999 Jul 01; 84(1):51-7. PubMed ID: 10404851
    [Abstract] [Full Text] [Related]

  • 40. Temporal repolarization inhomogeneity and reperfusion arrhythmias in patients undergoing successful primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction: impact of admission troponin T.
    Bonnemeier H, Wiegand UK, Giannitsis E, Schulenburg S, Hartmann F, Kurowski V, Bode F, Tölg R, Katus HA, Richardt G.
    Am Heart J; 2003 Mar 01; 145(3):484-92. PubMed ID: 12660672
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.